Boral has denied that shareholders bringing two class actions against it over financial irregularities in its North America windows business suffered any loss, saying that […]
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would […]
The applicant in a Federal Court class action against NAB superannuation trustee NULIS has been ordered to find a sample group member in light of […]
The Federal Court has dealt US drug giant Merck Sharp & Dohme a devastating blow, overturning an “untenable” patent term extension which would have protected […]
IP Australia has appealed a ruling granting drug company Ono Pharmaceutical a patent extension for a cancer immunotherapy drug, calling it an “impermissible gloss” on […]
In a win for a long-running class action against US auto giant Ford on behalf of owners of 70,000 vehicles, a judge has found that […]
A judge has overturned a ruling from the Australian Patent Office that shortened the amount of time available to companies under patent term extensions, saying […]
The judge overseeing a conflicted remuneration class action against Suncorp has locked in a trial date for May next year over the protests of the […]
A judge has found he has power to order that opt out notices be sent to a limited number of Boral shareholders eligible to join […]
A judgment in a heated carriage fight between three class actions against construction giant Boral provides some guidance to law firms about conduct that could […]